← Leaderboards
Melissa P Wasserstein
Icahn School Of Medicine At Mount Sinai
$1,452,006
Attributed
$1,452,006
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $935.1K · FY2006–09$1M$750K$500K$250K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$1,452,006 · 7
By mechanism
M01$1,452,006 · 7
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Nathan E Goldstein$9,630,744
- Silvia De Rubeis$5,011,415
- Melissa Pittel Wasserstein$13,874,586
- Bruce D Gelb$39,999,464
- Yong Zhao$2,544,644
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelMetabolicSafetySourceFundingGrantInstitutionResourcesComputer Retrieval Of Information On Scientific Projects DatabaseUnited States National Institutes Of HealthAcidsCessation Of LifeChildhoodChinese Hamster Ovary CellCardiomyopathiesAlpha-GlucosidaseGlucosidaseGlycogenDissociationEnrollmentEnzymesEnzyme Replacement TherapyDepositionGlycogen Storage Disease Type Ii
Grant awards (7)
AN OPEN - LABEL EXTENSION STUDY OF PATIENTS WITH LATE-ONSET POMPE DISEASE$37,680
M01 · FY2009 · RR · contact PI
SINGLE SUBCUTANEOUS DOSES OF RAVPAL-PEG IN SUBJECTS WITH PHENYLKETONURIA$4,649
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: MYOZYME TREATMENT IN PATIENTS WITH LATE-ONSET ONSET POMPE DISEAS$89,034
M01 · FY2008 · RR · contact PI
AN OPEN - LABEL EXTENSION STUDY OF PATIENTS WITH LATE-ONSET POMPE DISEASE$44,517
M01 · FY2008 · RR · contact PI
SAFETY, EFFICACY & PHARMACOKINETICS OF MYOZYME IN PATIENTS WITH POMPE DISEASE$341,011
M01 · FY2007 · RR · contact PI
NATURAL HISTORY AND TREATMENT OF GAUCHER DISEASE$861,121
M01 · FY2006 · RR · contact PI
MYOZYME TREATMENT IN PATIENTS WITH LATE ONSET POMPE DISEASE$73,994
M01 · FY2006 · RR · contact PI